FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Bader

Research Profile

Procedures

Living Beings

Disorders

Chemicals & Drugs

Antigens, CD34

Concepts & Ideas

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
R Beier; Arndt Borkhardt; U Creutzig; Karoline Ehlert; Matthias Eyrich; Johann Greil; Bernd Gruhn; Rupert Handgretinger; W Holter; Thomas Klingebiel; Bernhard Kremens; Peter Lang; C Mauz-Körholz; R Meisel; I Müller; Christina Peters; Dirk Reinhardt; André Schrauder; Ansgar Schulz; F R Schuster; Petr Sedlacek; Brigitte Strahm; Karl-Walter Sykora; Wilhelm Wössmann; Martin Zimmermann; Michael H Albert; Peter Bader; M G Sauer
Allo-SCT using BU, CY and melphalan for children with AML in second CR.
R Beier; Karoline Ehlert; Matthias Eyrich; Johann Greil; Bernd Gruhn; W Holter; Manfred Hönig; R Meisel; I Müller; W Nürnberger; M Sauer; Paul G Schlegel; Ansgar Schulz; K D Stachel; Meinolf Suttorp; Christian Urban; Wilhelm Wössmann; Martin Zimmermann; Peter Bader; Karl-Walter Sykora
Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience.
Jan Sörensen; Peter Bader; Andrea Jarisch; Ulrike Köhl; Erhard Seifried; Carmelo Smorta; Halvard Bönig
Pediatric apheresis with a novel apheresis device with electronic interface control.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Bader (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: R Beier; Arndt Borkhardt; U Creutzig; Karoline Ehlert; Matthias Eyrich; Johann Greil; Bernd Gruhn; Rupert Handgretinger; W Holter; Thomas Klingebiel; Bernhard Kremens; Peter Lang; C Mauz-Körholz; R Meisel; I Müller; Christina Peters; Dirk Reinhardt; André Schrauder; Ansgar Schulz; F R Schuster; Petr Sedlacek; Brigitte Strahm; Karl-Walter Sykora; Wilhelm Wössmann; Martin Zimmermann; Michael H Albert; Peter Bader; M G Sauer
Allo-SCT using BU, CY and melphalan for children with AML in second CR.
Bone marrow transplantation 2013;48(5):651-6.
2013: R Beier; Karoline Ehlert; Matthias Eyrich; Johann Greil; Bernd Gruhn; W Holter; Manfred Hönig; R Meisel; I Müller; W Nürnberger; M Sauer; Paul G Schlegel; Ansgar Schulz; K D Stachel; Meinolf Suttorp; Christian Urban; Wilhelm Wössmann; Martin Zimmermann; Peter Bader; Karl-Walter Sykora
Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience.
Bone marrow transplantation 2013;48(4):491-501.
2013: Jan Sörensen; Peter Bader; Andrea Jarisch; Ulrike Köhl; Erhard Seifried; Carmelo Smorta; Halvard Bönig
Pediatric apheresis with a novel apheresis device with electronic interface control.
Transfusion 2013;53(4):761-5.
2013: Patrick C Baer; Helmut Geiger; Michael Krause; Selim Kuçi; Zyrafete Kuçi; Peter Bader; Stefan Zielen; Ralf Schubert
Comprehensive phenotypic characterization of human adipose-derived stromal/stem cells and their subsets by a high throughput technology.
Stem cells and development 2013;22(2):330-9.
2012: U Thiel; I T von Lüttichau; A Wawer; Willi Woessmann; P Wolf; Peter Bader; F Blaeschke; A Borkhardt; M Bregni; Uta Dirksen; G Ehninger; Matthias Eyrich; B Gruhn; T G P Grunewald; R Handgretinger; E Holler; H Jürgens; C Klein; Thomas Klingebiel; E Koscielniak; P Lang; Hans-Jürgen Laws; C Mauz-Körholz; C Peters; G H S Richter; Paul G Schlegel; A H Schmidt; K-W Sykora; Stefan Burdach
Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma.
Klinische Pädiatrie 2012;224(6):353-8.
2012: Thomas Lion; Sandra Preuner; E Roosnek; B Saglio; A Serra; C Steward; M Tilanus; Mirjam van der Burg; J J M van Dongen; J van Loon; Franz Watzinger; Gisela Barbany; Andrea Biondi; H Cavé; F Colnaghi; M Crampe; L de Vries; R de Weger; Florian Frommlet; M Gonzalez; J Harvey; M Hermanson; Hermann Kreyenberg; M Lawler; C Acquaviva; M Alcoceba; Peter Bader
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation.
Leukemia 2012;26(8):1821-8.
2012: Thomas Klingebiel; Peter Bader
[Stem cell transplantation for acute leukemias: Balancing risks and benefits of different treatment methods].
Pharmazie in unserer Zeit 2012;41(3):222-7.
2012: Konrad Bochennek; S Erben; Ruth Esser; Wolfgang Glienke; Thomas Klingebiel; Thomas Lehrnbecher; Dirk Schwabe; J Soerensen; S Wehner; Peter Bader; Ulrike Koehl
Impact of minimal residual disease detection prior to autologous stem cell transplantation for post-transplant outcome in high risk neuroblastoma.
Klinische Pädiatrie 2012;224(3):139-42.
2012: Sylvia Borchers; Melanie Bremm; Elke Dammann; Matthias Eder; Ruth Esser; Arnold Ganser; Andrea Jarisch; Thomas Klingebiel; Thomas Lehrnbecher; Hans Martin; Brigitte Pabst; Gisbert Schneider; Michael Stadler; Eva M Weissinger; Benno Wölk; Meral Yildiz; Peter Bader; Ulrike Koehl
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.
PloS one 2012;7(12):e50248.
2012: Eva Rettinger; Andreas Volk; Winfried S Wels; Andre Willasch; Halvard Boenig; Simone Fulda; Thomas Klingebiel; Ewa Koscielniak; Hermann Kreyenberg; Selim Kuçi; Vida Meyer; Peter Bader
Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models.
Frontiers in oncology 2012;2():32.
2011: Eva Rettinger; Paul G Schlegel; Brigitte Strahm; Andre M Willasch; Wilhelm Woessmann; Michael H Albert; Arndt Borkhardt; Stefan Burdach; Bernd Gruhn; Wolfgang Holter; Thomas Klingebiel; Bernhard Kremens; Hermann Kreyenberg; Christine Mauz-Koerholz; Peter Bader
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation.
Blood 2011;118(20):5681-8.
2011: Zyrafete Kuçi; Ralf Lieberz; Ralf Schubert; Susanne Zircher; Halvard Bönig; Reinhard Henschler; Thomas Klingebiel; Stefanie Koller; Selim Kuçi; Peter Bader
Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties.
Cytotherapy 2011;13(10):1193-204.
2011: Melanie Bremm; Gesine Bug; Annekathrin Heinze; Sabine Huenecke; Michael Kapinsky; Thomas Klingebiel; Thomas Lehrnbecher; Regine Mueller; Eva Ponstingl; Andrea Quaiser; Gisbert Schneider; Peter Bader; Claudia Brehm; Ulrike Koehl
Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
Journal of immunological methods 2011;373(1-2):36-44.
2011: Peter Bader; Halvard Bönig; Matthias Dürken; Ruth Esser; Jörg Faber; Andrea Jarisch; Ulrike Koehl; Thomas Krenn; Eva Ponstingl; Harald Reinhardt; Jan Soerensen; Andre Willasch; Thomas Klingebiel
Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells.
Best practice & research. Clinical haematology 2011;24(3):331-7.
2011: Mirjam van der Burg; J J M van Dongen; F Watzinger; Andre Willasch; M Alcoceba; Peter Bader; Barbara H Barendregt; M G Díaz; J Harvey; Hermann Kreyenberg; Thomas Lion; Sandra Preuner; E Roosnek
Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats.
Leukemia 2011;25(9):1467-70.
2011: Hermann Kreyenberg; Christine Mauz-Koerholz; Claudia Rossig; Paul G Schlegel; André Schrauder; Blanca Schuster; Daniel Stachel; Brigitte Strahm; Andre Willasch; Christina Bayer; James F Beck; Stefan Burdach; Tje Lin Chung; Monika Führer; Bernd Gruhn; Ernst Holler; Andrea Jarisch; Hartmut Kabisch; Thomas Klingebiel; Bernhard Kremens; Peter Bader
NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation.
Blood 2011;118(4):1181-4.
2011: A Rosenhagen; M Bernhörster; L Vogt; B Weiss; A Senn; S Arndt; K Siegler; M Jung; Peter Bader; Winfried Banzer
Implementation of structured physical activity in the pediatric stem cell transplantation.
Klinische Pädiatrie 2011;223(3):147-51.
2011: Claudia Brehm; Melanie Bremm; Ruth Esser; Sabine Huenecke; Thomas Klingebiel; Stephan Kloess; Hermann Kreyenberg; Heiko Muhl; Jakob R Passweg; Andrea Quaiser; Dirk Schwabe; Christian Seidl; Jan Soerensen; Peter Bader; Petra S A Becker; Ulrike Koehl
IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.
PloS one 2011;6(11):e27351.
2011: Caroline M Wernicke; Hendrik Juenger; Peter Bader; Stefan Burdach; Michaela Doering; Thomas G P Grunewald; Ulrike Koehl; Hans-Jochem Kolb; Selim Kuci; Zyrafete Kuci; Anita Lawitschka; Ingo Mueller; Christina Peters; Irene von Luettichau
Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.
International archives of medicine 2011;4(1):27.
2010: Stephan Kloess; Sabine Huenecke; Daniel Piechulek; Ruth Esser; Joachim Koch; Claudia Brehm; Jan Soerensen; Tanja Gardlowski; Andrea Brinkmann; Peter Bader; Jakob Passweg; Thomas Klingebiel; Dirk Schwabe; Ulrike Koehl
IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
European journal of immunology 2010;40(11):3255-67.
2010: Nicolaus Kröger; Ulrike Bacher; Peter Bader; Sebastian Böttcher; Michael J Borowitz; Peter Dreger; Issa Khouri; Eduardo Olavarria; Jerald Radich; Wendy Stock; Julie M Vose; Daniel Weisdorf; Andre Willasch; Sergio Giralt; Michael Bishop; ALAN WAYNE
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(10):1325-46.
2010: Nicolaus Kröger; Ulrike Bacher; Peter Bader; Sebastian Böttcher; Michael J Borowitz; Peter Dreger; Issa Khouri; Homer A Macapinlac; Homer Macapintac; Eduardo Olavarria; Jerald Radich; Wendy Stock; Julie M Vose; Daniel Weisdorf; Andre Willasch; Sergio Giralt; Michael Bishop; ALAN WAYNE
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(9):1187-211.
2010: Selim Kuçi; Eva Rettinger; Bernhard Voss; Gerrit Weber; Miriam Stais; Hermann Kreyenberg; Andre Willasch; Zyrafete Kuçi; Ewa Koscielniak; Stephan Klöss; Dorothee von Laer; Thomas Klingebiel; Peter Bader
Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.
Haematologica 2010;95(9):1579-86.
2010: Selim Kuçi; Zyrafete Kuçi; Hermann Kreyenberg; Erika Deak; Kathrin Pütsch; Sabine Huenecke; Chandrasekhar Amara; Stefanie Koller; Eva Rettinger; Manuel Grez; Ulrike Koehl; Hatixhe Latifi-Pupovci; Reinhard Henschler; Torsten Tonn; Dorothee von Laer; Thomas Klingebiel; Peter Bader
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.
Haematologica 2010;95(4):651-9.
2010: M Koenig; S Huenecke; E Salzmann-Manrique; Ruth Esser; R Quaritsch; D Steinhilber; H H Radeke; Hans Martin; Peter Bader; Thomas Klingebiel; Dirk Schwabe; G Schneider; Thomas Lehrnbecher; A Orth; Ulrike Koehl
Multivariate analyses of immune reconstitution in children after allo-SCT: risk-estimation based on age-matched leukocyte sub-populations.
Bone marrow transplantation 2010;45(4):613-21.
2010: Terry J Fry; Andre Willasch; Peter Bader
The graft-versus-tumor effect in pediatric malignancy.
Pediatric clinics of North America 2010;57(1):67-81.
2010: Sabine Huenecke; Stefanie-Yvonne Zimmermann; Stephan Kloess; Ruth Esser; Andrea Brinkmann; Lars Tramsen; Melanie Koenig; Stephanie Erben; Christian Seidl; Torsten Tonn; Angelika Eggert; Alexander Schramm; Peter Bader; Thomas Klingebiel; Thomas Lehrnbecher; Jakob Robert Passweg; Jan Soerensen; Dirk Schwabe; Ulrike Koehl
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(2):200-10.
2010: A Willasch; S Eing; G Weber; Selim Kuçi; G Schneider; J Soerensen; Andrea Jarisch; E Rettinger; Ulrike Koehl; Thomas Klingebiel; Hermann Kreyenberg; Peter Bader
Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis.
Bone marrow transplantation 2010;45(1):181-9.
2009: G Weber; J Karbach; Selim Kuçi; Hermann Kreyenberg; A Willasch; Ewa Koscielniak; Torsten Tonn; Thomas Klingebiel; Winfried S Wels; E Jäger; Peter Bader
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.
Leukemia 2009;23(9):1634-42.
2009: A M Willasch; B Gruhn; T Coliva; M Kalinova; G Schneider; Hermann Kreyenberg; D Steinbach; G Weber; I H I M Hollink; Christian M Zwaan; A Biondi; V H J van der Velden; Dirk Reinhardt; G Cazzaniga; Peter Bader; Jan Trka
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.
Leukemia 2009;23(8):1472-9.
2009: Selim Kuçi; Zyrafete Kuçi; Hatixhe Latifi-Pupovci; Dietrich Niethammer; Rupert Handgretinger; Michael Schumm; Gernot Bruchelt; Peter Bader; Thomas Klingebiel
Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine.
Current stem cell research & therapy 2009;4(2):107-17.
2009: Peter Bader; Hermann Kreyenberg; Günter H R Henze; Cornelia Eckert; Miriam Reising; Andre Willasch; Andrea Barth; Arndt Borkhardt; Christina Peters; Rupert Handgretinger; Karl-Walter Sykora; Wolfgang Holter; Hartmut Kabisch; Thomas Klingebiel; Arend von Stackelberg
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(3):377-84.
2008: Thomas Klingebiel; Dirk Reinhardt; Peter Bader
Place of HSCT in treatment of childhood AML.
Bone marrow transplantation 2008;42 Suppl 2():S7-9.
2008: Johannes Schulze; Peter Bader; Ulrike Henke; Markus A Rose; Stefan Zielen
Severe bullous pemphigoid in an infant--successful treatment with rituximab.
Pediatric dermatology 2008;25(4):462-5.
2008: Thomas Klingebiel; Peter Bader
Delayed lymphocyte infusion in children given SCT.
Bone marrow transplantation 2008;41 Suppl 2():S23-6.
2008: Olaf Beck; Ulrike Koehl; Lars Tramsen; Sabine Mousset; Jean-Paul Latgé; Katrin Müller; Dirk Schwabe; Peter Bader; Thomas Klingebiel; Thomas Lehrnbecher
Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood.
Journal of immunological methods 2008;335(1-2):41-5.
2008: Selim Kuçi; Zyrafete Kuçi; Susanne Schmid; Guido Seitz; I Müller; Andreas Dufke; T Leimig; G Murti; Roland Jurecic; Michael Schumm; Peter Lang; Gernot Bruchelt; Peter Bader; Thomas Klingebiel; Dietrich Niethammer; Rupert Handgretinger
Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells.
Cell proliferation 2008;41(1):12-27.
2008: Sophie Archambeault; Nikki J Flores; Ayami Yoshimi; Christian P Kratz; Miriam Reising; Alexandra Fischer; Peter Noellke; Franco Locatelli; Petr Sedlacek; Christian Flotho; Marco Zecca; Peter D Emanuel; Robert P Castleberry; Charlotte M Niemeyer; Peter Bader; Mignon L Loh
Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia.
Blood 2008;111(3):1124-7.
2008: Ulrike Koehl; Konrad Bochennek; Ruth Esser; A Brinkmann; R Quaritsch; M Becker; J Soerensen; Peter Bader; Dirk Schwabe; Thomas Klingebiel; J Fischer; Stefanie-Yvonne Zimmermann
ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells.
International journal of hematology 2008;87(1):98-105.
2008: Peter Lang; Ingo Mueller; Johann Greil; Peter Bader; Michael Schumm; Matthias Pfeiffer; Walter Hoelle; Thomas Klingebiel; Frank Heinzelmann; Claus Belka; Paul G Schlegel; Bernhard Kremens; Willi Woessmann; Rupert Handgretinger
Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.
Blood cells, molecules & diseases 2008;40(1):33-9.
2007: Brigitte Strahm; Franco Locatelli; Peter Bader; K Ehlert; Bernhard Kremens; Felix Zintl; Monika Führer; D Stachel; Karl-Walter Sykora; Petr Sedlacek; Irith Baumann; Charlotte M Niemeyer
Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood.
Bone marrow transplantation 2007;40(4):329-33.
2007: V H J van der Velden; Giovanni Cazzaniga; André Schrauder; J Hancock; Peter Bader; E R Panzer-Grumayer; T Flohr; R Sutton; H Cave; H O Madsen; Jean-Michel Cayuela; Jan Trka; Cornelia Eckert; Letizia Foroni; Udo zur Stadt; Kheira Beldjord; Thorsten Raff; C. Ellen van der Schoot; Jacques J M van Dongen
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.
Leukemia 2007;21(4):604-11.
2007: Maite Hartwig; Steffen Weigel; T Bernig; Peter Bader; R Dölken; J Beck
Maintenance immunotherapy by repetitive low-dose donor lymphocytes infusions in a child with relapse state aml after allogeneic stem cell transplantation.
Pediatric hematology and oncology 2007;24(2):137-40.
2007: Ulrike Koehl; Konrad Bochennek; Stefanie-Yvonne Zimmermann; Thomas Lehrnbecher; Jan Sörensen; Ruth Esser; C Andreas; C Kramm; Hans-Peter Grüttner; E Falkenberg; A Orth; Peter Bader; Dirk Schwabe; Thomas Klingebiel
Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.
Bone marrow transplantation 2007;39(5):269-78.
2007: Andre Willasch; Gaby Schneider; Britta Sofia Reincke; Nona Shayegi; Hermann Kreyenberg; Selim Kuci; Gerrit Weber; Bert Van Der Reijden; Dietrich Niethammer; Thomas Klingebiel; Peter Bader
Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement.
Laboratory hematology : official publication of the International Society for Laboratory Hematology 2007;13(3):73-84.
2006: Thomas Klingebiel; Peter Bader; G Hollatz; Ulrike Koehl; Thomas Lehrnbecher; Roland Meisel; Dagmar Dilloo
Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
Klinische Pädiatrie 2006;218(6):355-65.
2006: Andre Willasch; Walter Hoelle; Hermann Kreyenberg; Dietrich Niethammer; Rupert Handgretinger; Peter Lang; James F Beck; Thomas Klingebiel; Peter Bader
Outcome of allogeneic stem cell transplantation in children with non-malignant diseases.
Haematologica 2006;91(6):788-94.
2006: Thomas Lehrnbecher; Martina Becker; Dirk Schwabe; Ulrike Köhl; Susanne Kriener; Klaus-Peter Hunfeld; Helga Schmidt; Peter A Beyer; Thomas Klingebiel; Peter Bader; Jan Sörensen
Primary intestinal aspergillosis after high-dose chemotherapy and autologous stem cell rescue.
The Pediatric infectious disease journal 2006;25(5):465-6.
2006: Jürgen Sonnemann; K Saravana Kumar; Sandra Heesch; Cornelia Müller; Christoph Hartwig; Manfred Maass; Peter Bader; James F Beck
Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
International journal of oncology 2006;28(3):755-66.
2006: Olaf Beck; Christian Seidl; Thomas Lehrnbecher; Hermann Kreyenberg; Dirk Schwabe; Thomas Klingebiel; Erhard Seifried; Peter Bader; Ulrike Koehl
Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci.
European journal of haematology 2006;76(3):237-44.
2005: Ulrike Koehl; Ruth Esser; Stefanie-Yvonne Zimmermann; Torsten Tonn; Rouslan Kotchetkov; T Bartling; Jan Sörensen; Hans-Peter Grüttner; Peter Bader; Erhard Seifried; Hans Martin; P Lang; Jakob R Passweg; Thomas Klingebiel; Dirk Schwabe
Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
Klinische Pädiatrie 2005;217(6):345-50.
2005: Tobias Feuchtinger; Celine Richard; Matthias Pfeiffer; F Neuhäuser; J Lücke; Rupert Handgretinger; Johann Greil; Peter Bader; Thomas Klingebiel; Paul G Schlegel; Gerhard Jahn; Dietrich Niethammer; Peter Lang
Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update.
Klinische Pädiatrie 2005;217(6):339-44.
2005: Peter Lang; Michael Schumm; Johann Greil; Peter Bader; Thomas Klingebiel; I Müller; Tobias Feuchtinger; Matthias Pfeiffer; Paul G Schlegel; Dietrich Niethammer; Rupert Handgretinger
A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.
Klinische Pädiatrie 2005;217(6):334-8.
2005: Udo Kontny; Sridhar Boppana; Andreas Jung; Heike Goebel; Brigitte Strahm; Anke Peters; Sabine Dormann; Martin Werner; Peter Bader; Paul Fisch; Charlotte Niemeyer
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Haematologica 2005;90 Suppl():ECR27.
2005: Ayami Yoshimi; Peter Bader; Susanne Matthes-Martin; Jan Starý; Petr Sedlacek; Ulrich Duffner; Thomas Klingebiel; Dagmar Dilloo; Wolfgang Holter; Felix Zintl; Bernhard Kremens; Karl-Walter Sykora; Christian Urban; Henrik Hasle; Elisabeth Korthof; Tom Révész; Alain Fischer; Peter Nöllke; Franco Locatelli; Charlotte M Niemeyer
Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.
Leukemia 2005;19(6):971-7.
2005: Ayami Yoshimi; Charlotte M Niemeyer; Viktoria Bohmer; Ulrich Duffner; Brigitte Strahm; Hermann Kreyenberg; Dagmar Dilloo; Felix Zintl; Alexander Claviez; Wilhelm Wössmann; Bernhard Kremens; Wolfgang Holter; Dietrich Niethammer; James F Beck; Udo Kontny; Peter Nöllke; Thomas Klingebiel; Peter Bader
Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
British journal of haematology 2005;129(4):542-9.
2005: Thomas Klingebiel; Peter Lang; Michael Schumm; Ulrike Koehl; Peter Bader; Dirk Schwabe; Paul G Schlegel; Matthias Eyrich; Johann Greil; James F Beck; Dietrich Niethammer; Rupert Handgretinger
Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia.
Pathologie-biologie 2005;53(3):159-61.
2005: Gunter Kerst; Hermann Kreyenberg; Carmen Roth; Catrin Well; Klaus Dietz; Elaine Coustan-Smith; Dario Campana; Ewa Koscielniak; Charlotte Niemeyer; Paul G Schlegel; Ingo Müller; Dietrich Niethammer; Peter Bader
Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR.
British journal of haematology 2005;128(6):774-82.
2005: Jürgen Sonnemann; Jennifer Gänge; K Saravana Kumar; Cornelia Müller; Peter Bader; James F Beck
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines.
Investigational new drugs 2005;23(2):99-109.
2005: Matthias Eyrich; Gernot Wollny; Nikolaj Tzaribaschev; Klaus Dietz; Dorothee Brügger; Peter Bader; Peter Lang; Karin Schilbach; Beate Winkler; Dietrich Niethammer; Paul G Schlegel
Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(3):194-205.
2005: Peter Bader; Charlotte Niemeyer; Andre Willasch; Hermann Kreyenberg; Brigitte Strahm; Bernhard Kremens; Bernd Gruhn; Dagmar Dilloo; Josef Vormoor; Peter Lang; Dietrich Niethammer; Thomas Klingebiel; James F Beck
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy.
British journal of haematology 2005;128(5):649-58.
2005: Peter Bader; Dietrich Niethammer; Andre Willasch; Hermann Kreyenberg; Thomas Klingebiel
How and when should we monitor chimerism after allogeneic stem cell transplantation?
Bone marrow transplantation 2005;35(2):107-19.
2005: Franco Locatelli; Peter Nöllke; Marco Zecca; Elisabeth Korthof; Edoardo Lanino; Christina Peters; Andrea Pession; Hartmut Kabisch; Cornelio Uderzo; Carmen S Bonfim; Peter Bader; Dagmar Dilloo; Jan Stary; Alexandra Fischer; Tom Révész; Monika Führer; Henrik Hasle; Monika M Trebo; Marry M van den Heuvel-Eibrink; SUSANNA FENU; Brigitte Strahm; Giovanna Giorgiani; Mario Regazzi Bonora; Ulrich Duffner; Charlotte M Niemeyer
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.
Blood 2005;105(1):410-9.
2004: Peter Lang; Johann Greil; Peter Bader; Rupert Handgretinger; Thomas Klingebiel; Michael Schumm; Paul G Schlegel; Tobias Feuchtinger; Matthias Pfeiffer; Hans Scheel-Walter; Monika Führer; David Martin; Dietrich Niethammer
Long-term outcome after haploidentical stem cell transplantation in children.
Blood cells, molecules & diseases 2004;33(3):281-7.
2004: Thomas Klingebiel; Rupert Handgretinger; Peter Lang; Peter Bader; Dietrich Niethammer
Haploidentical transplantation for acute lymphoblastic leukemia in childhood.
Blood reviews 2004;18(3):181-92.
2004: Peter Bader; Charlotte Niemeyer; Gerrit Weber; Tiziana Coliva; Vincenzo Rossi; Hermann Kreyenberg; Anja Gerecke; Andrea Biondi
WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
European journal of haematology 2004;73(1):25-8.
2004: Jürgen Sonnemann; Volker Gekeler; Katrin Ahlbrecht; Klaus Brischwein; Chao Liu; Peter Bader; Cornelia Müller; Dietrich Niethammer; James F Beck
Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel.
Cancer letters 2004;209(2):177-85.
2004: Peter Bader; Hermann Kreyenberg; Walter Hoelle; Gregor Dueckers; Rupert Handgretinger; Peter Lang; Bernhard Kremens; Dagmar Dilloo; Karl-Walter Sykora; Martin Schrappe; Charlotte Niemeyer; Arend von Stackelberg; Bernd Gruhn; Günter Henze; Johann Greil; Dietrich Niethammer; Klaus Dietz; James F Beck; Thomas Klingebiel
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1696-705.
2004: Peter Bader; Hermann Kreyenberg; Walter Hoelle; Gregor Dueckers; Bernhard Kremens; Dagmar Dilloo; Karl-Walter Sykora; Charlotte Niemeyer; Dirk Reinhardt; Josef Vormoor; Bernd Gruhn; Peter Lang; Johann Greil; Rupert Handgretinger; Dietrich Niethammer; Thomas Klingebiel; James F Beck
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.
Bone marrow transplantation 2004;33(8):815-21.
2004: Peter Lang; Thomas Klingebiel; Peter Bader; Johann Greil; Michael Schumm; Paul G Schlegel; Matthias Eyrich; S Mueller-Weihrich; Dietrich Niethammer; Rupert Handgretinger
Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases.
Bone marrow transplantation 2004;33(1):25-32.
2004: Peter Lang; Peter Bader; Michael Schumm; Tobias Feuchtinger; Hermann Einsele; Monika Führer; Christof Weinstock; Rupert Handgretinger; Selim Kuci; David Martin; Dietrich Niethammer; Johann Greil
Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors.
British journal of haematology 2004;124(1):72-9.
2004: Walter Hoelle; James F Beck; Gregor Dueckers; Hermann Kreyenberg; Peter Lang; Bernd Gruhn; Monika Führer; Dietrich Niethammer; Thomas Klingebiel; Peter Bader
Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia.
Bone marrow transplantation 2004;33(2):219-23.
2004: Peter Bader; Hermann Kreyenberg
Analysis of chimerism after stem cell transplantation.
Methods in molecular medicine 2004;91():247-64.
2003: O Krejci; V H J van der Velden; Peter Bader; Hermann Kreyenberg; Nicholas J Goulden; J Hancock; M W Schilham; Arjan C Lankester; Tom Révész; Thomas Klingebiel; Jacques J M van Dongen
Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group.
Bone marrow transplantation 2003;32(8):849-51.
2003: A Wiesmann; Peter Bader; Christoph Faul; M Schnaidt; Lothar Kanz; Hermann Einsele
Successful haematopoietic stem cell transplantation from a matched unrelated donor following three graft failures from HLA-mismatched related donors.
Bone marrow transplantation 2003;32(7):729-31.
2003: M Koch; Peter Lang; Peter Bader; Hermann Kreyenberg; Michael Schumm; Hans Scheel-Walter; A Hochhaus; Dietrich Niethammer; Johann Greil
Successful unrelated allogeneic stem cell transplantation after treatment of lymphoid blast crisis CML with imatinib and imatinib-containing conditioning regimen in a 16-year-old male.
Bone marrow transplantation 2003;32(5):541-2.
2003: A Wiesmann; Peter Bader; D D; Christoph Faul; Lothar Kanz; Hermann Einsele
Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor.
Bone marrow transplantation 2003;32(5):511-3.
2003: Matthias Eyrich; Christine Leiler; Peter Lang; Karin Schilbach; Michael Schumm; Peter Bader; Johann Greil; Thomas Klingebiel; Rupert Handgretinger; Dietrich Niethammer; Paul G Schlegel
A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.
Bone marrow transplantation 2003;32(4):379-90.
2003: Nicholas J Goulden; Peter Bader; V H J van der Velden; John Moppett; Marco Schilham; Hans O Masden; Ondrej Krejci; Hermann Kreyenberg; Arjan C Lankester; Tom Révész; Thomas Klingebiel; Jacques Van Dongen
Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.
British journal of haematology 2003;122(1):24-9.
2003: Maren Tomaske; Axel Bosk; Matthias Eyrich; Peter Bader; Dietrich Niethammer
Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation.
British journal of haematology 2003;121(6):886-91.
2003: Hermann Einsele; Hans-Jörg Schäfer; Holger Hebart; Peter Bader; Christoph Meisner; Ludwig Plasswilm; Peter Liebisch; D D; Christoph Faul; Lothar Kanz
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.
British journal of haematology 2003;121(3):411-8.
2003: Peter Lang; Rupert Handgretinger; Dietrich Niethammer; Paul G Schlegel; Michael Schumm; Johann Greil; Peter Bader; Corinna Engel; Hans Scheel-Walter; Matthias Eyrich; Thomas Klingebiel
Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia.
Blood 2003;101(4):1630-6.
2003: Selim Kuçi; Johannes T Wessels; Hans-Jörg Bühring; Karin Schilbach; Michael Schumm; Guido Seitz; Jürgen Löffler; Peter Bader; Paul G Schlegel; Dietrich Niethammer; Rupert Handgretinger
Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells.
Blood 2003;101(3):869-76.
2002: Juergen Loeffler; Ralf Bauer; Holger Hebart; Daniel C Douek; Georg Rauser; Peter Bader; Hermann Einsele
Quantification of T-cell receptor excision circle DNA using fluorescence resonance energy transfer and the LightCycler system.
Journal of immunological methods 2002;271(1-2):167-75.
2002: Dorothee Brügger; Klaus Brischwein; Chao Liu; Peter Bader; Dietrich Niethammer; Volker Gekeler; James F Beck
Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations.
Anticancer research 2002;22(6C):4229-32.
2002: Peter Bader; J Hancock; Hermann Kreyenberg; Nicholas J Goulden; Dietrich Niethammer; Anthony Oakhill; Colin Steward; Rupert Handgretinger; James F Beck; Thomas Klingebiel
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.
Leukemia 2002;16(9):1668-72.
2002: Matthias Eyrich; Tanja Croner; Christine Leiler; Peter Lang; Peter Bader; Thomas Klingebiel; Dietrich Niethammer; Paul G Schlegel
Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors.
Blood 2002;100(5):1915-8.
2002: James F Beck; Thomas Klingebiel; Hermann Kreyenberg; A Schaudt; W Wölle; Dietrich Niethammer; Peter Bader
[Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing mixed chimerism].
Klinische Pädiatrie 2002;214(4):201-5.
2002: G Seitz; G Kohler; M Nehmzow; Gerd Lorenz; C Denzlinger; C Müller; Peter Bader; Klaus Brischwein; James F Beck
Potentially therapeutically relevant differences of antisense oligonucleotide uptake in CD34+ hematopoietic stem cells, leukemic blasts and cancer cells from patients.
Anticancer research 2002;22(3):1717-9.
2002: Peter Bader; G Dückers; Hermann Kreyenberg; Walter Hoelle; Gunter Kerst; Peter Lang; Johann Greil; Dietrich Niethammer; L F Beck; Thomas Klingebiel
Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.
Annals of hematology 2002;81 Suppl 2():S25-7.
2001: R Stilz; Frank Grünebach; Peter Bader; W Vogel; Lothar Kanz; Wolfram Brugger; Stefan Scheding
Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
Journal of hematotherapy & stem cell research 2001;10(6):777-85.
2001: Matthias Eyrich; Peter Lang; S Lal; Peter Bader; Rupert Handgretinger; Thomas Klingebiel; Dietrich Niethammer; Paul G Schlegel
A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors.
British journal of haematology 2001;114(2):422-32.
2001: James F Beck; Dorothee Brügger; Klaus Brischwein; Chao Liu; Peter Bader; Dietrich Niethammer; Volker Gekeler
Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Japanese journal of cancer research : Gann 2001;92(8):896-903.
2001: Rupert Handgretinger; Peter Lang; Michael Schumm; Matthias Pfeiffer; S Gottschling; B Demirdelen; Peter Bader; Selim Kuci; Thomas Klingebiel; Dietrich Niethammer
Immunological aspects of haploidentical stem cell transplantation in children.
Annals of the New York Academy of Sciences 2001;938():340-57; discussion 357-8.
2001: Rupert Handgretinger; Thomas Klingebiel; Peter Lang; Michael Schumm; S Neu; A Geiselhart; Peter Bader; Paul G Schlegel; Johann Greil; D Stachel; R J Herzog; Dietrich Niethammer
Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.
Bone marrow transplantation 2001;27(8):777-83.
2000: Paul G Schlegel; Matthias Eyrich; Peter Bader; Rupert Handgretinger; Peter Lang; Dietrich Niethammer; Thomas Klingebiel
OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants.
British journal of haematology 2000;111(2):668-73.
2000: Holger Hebart; Jürgen Löffler; H Reitze; A Engel; Ulrike Schumacher; Thomas Klingebiel; Peter Bader; A Böhme; H Martin; D Bunjes; WV Kern; Lothar Kanz; Hermann Einsele
Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia.
British journal of haematology 2000;111(2):635-40.
2000: Hermann Einsele; Holger Hebart; C Kauffmann-Schneider; Christian Sinzger; Gerhard Jahn; Peter Bader; Thomas Klingebiel; K Dietz; Jürgen Löffler; C Bokemeyer; CA Müller; Lothar Kanz
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.
Bone marrow transplantation 2000;25(7):757-63.
2000: Peter Bader; K Stoll; S Huber; A Geiselhart; Rupert Handgretinger; Charlotte Niemeyer; H Einsele; Paul G Schlegel; Dietrich Niethammer; J Beck; Thomas Klingebiel
Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse.
British journal of haematology 2000;108(4):761-8.
1999: Peter Bader; Thomas Klingebiel; A Schaudt; U Theurer-Mainka; Rupert Handgretinger; Peter Lang; Dietrich Niethammer; James F Beck
Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children.
Leukemia 1999;13(12):2079-86.
1999: FS Eckstein; MK Heinemann; GJ Mielke; Annette Greschniok; Peter Bader; Gerhard Ziemer
Resection of a large right atrial hemangioma in a neonate after prenatal diagnosis.
The Annals of thoracic surgery 1999;68(3):1074-5.
1999: Axel Bosk; Peter Bader; GJ Mielke; MK Heinemann; Ludger Sieverding
[Extensive cavernous capillary hemangioma of the right atrium in a newborn infant].
Zeitschrift für Geburtshilfe und Neonatologie 1999;203(3):120-2.
1999: Dorothee Brügger; H Herbart; Volker Gekeler; G Seitz; Chao Liu; T Klingebiel; T Orlikowsky; H Einsele; C Denzlinger; Peter Bader; Dietrich Niethammer; James F Beck
Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts.
Leukemia research 1999;23(5):467-75.
1999: Rupert Handgretinger; Michael Schumm; Peter Lang; Johann Greil; A Reiter; Peter Bader; Dietrich Niethammer; Thomas Klingebiel
Transplantation of megadoses of purified haploidentical stem cells.
Annals of the New York Academy of Sciences 1999;872():351-61; discussion 361-2.
1998: Thomas Klingebiel; Peter Bader; Roland Bares; J Beck; Barbara Hero; H Jürgens; Peter Lang; Dietrich Niethammer; B Rath; Rupert Handgretinger
Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study.
European journal of cancer (Oxford, England : 1990) 1998;34(9):1398-402.
1998: Holger Hebart; D Gamer; Juergen Loeffler; C Mueller; Christian Sinzger; Gerhard Jahn; Peter Bader; T Klingebiel; Lothar Kanz; Hermann Einsele
Evaluation of Murex CMV DNA hybrid capture assay for detection and quantitation of cytomegalovirus infection in patients following allogeneic stem cell transplantation.
Journal of clinical microbiology 1998;36(5):1333-7.
1998: James F Beck; B Bohnet; Dorothee Brügger; J Dietl; R J Scheper; Peter Bader; Dietrich Niethammer; Volker Gekeler
Expression analysis of protein kinase C isozymes and multidrug resistance associated genes in ovarian cancer cells.
Anticancer research 1998;18(2A):701-5.
1998: Peter Bader; J Beck; A Frey; Paul G Schlegel; H Hebarth; Rupert Handgretinger; H Einsele; Charlotte Niemeyer; N Benda; C Faul; L Kanz; Dietrich Niethammer; Thomas Klingebiel
Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
Bone marrow transplantation 1998;21(5):487-95.
1998: Paul G Schlegel; Hans P Haber; J Beck; S Krümpelmann; R Handgretinger; Peter Bader; M Bierings; Dietrich Niethammer; Thomas Klingebiel
Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin.
Annals of hematology 1998;76(1):37-41.
1998: J Beck; B Bohnet; Dorothee Brügger; Peter Bader; J Dietl; R J Scheper; R Kandolf; Chao Liu; Dietrich Niethammer; Volker Gekeler
Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.
British journal of cancer 1998;77(1):87-91.
1997: Peter Bader; J Beck; Paul G Schlegel; Rupert Handgretinger; Dietrich Niethammer; Thomas Klingebiel
Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse?
Bone marrow transplantation 1997;20(1):79-81.
1997: Peter Bader; W Hölle; Thomas Klingebiel; Rupert Handgretinger; N Benda; Paul G Schlegel; Dietrich Niethammer; J Beck
Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
Bone marrow transplantation 1997;19(7):697-702.
1996: Peter Bader; W Hölle; T Klingebiel; R Handgretinger; Dietrich Niethammer; J Beck
Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT.
Anticancer research 1996;16(4A):1759-63.
1995: Thomas Klingebiel; Rupert Handgretinger; M Herter; T Eppinger; Peter Bader; Peter Lang; R Dopfer; H Scheel-Walter; U Haus; Dietrich Niethammer
Autologous transplantation with peripheral blood stem cells in children and young adults after myeloablative treatment: nonrandomized comparison between GM-CSF and G-CSF for mobilization.
Journal of hematotherapy 1995;4(4):307-14.